Abstract
Genitourinary syndrome of menopause (GSM) is common among postmenopausal women, but, in general, not all of the patients seek medical advice as this sensitive issue can cause them embarrassment.
Objectives
To explore the prevalence of GSM among Thai postmenopausal women and their disclosure of and attitude towards GSM.
Methods
A questionnaire was used to obtain information on GSM from 499 Thai postmenopausal women who attended the Menopause Clinic at Maharaj Nakorn Chiang Mai Hospital, Chiang Mai, Thailand, from November 2015 to August 2016.
Results
The mean age of the 499 participants was 57.8 ± 7.2 years. It was notable that 87.2% of them had had GSM, and the prevalence increased with age. The most common symptoms were nocturia (77.7%) and vaginal dryness (51.7%). Among the symptomatic patients, 63.0% conveyed their problem to other people, i.e., friends and family, while 52.9% of them never reported to health care providers. The most common reason for not talking about their GSM was the acceptance of it being part of the natural aging process.
Conclusions
GSM is common among Thai postmenopausal women. The prevalence of non-reporting is high and underreported.
Similar content being viewed by others
References
Chua Y, Limpaphayom KK, Cheng B, Ho CM, Sumapradja K, Altomare C, et al. Genitourinary syndrome of menopause in five Asian countries: results from the pan-Asian REVIVE survey. Climacteric. 2017;20(4):367–73.
Moral E, Delgado JL, Carmona F, Caballero B, Guillan C, Gonzalez PM, et al. Genitourinary syndrome of menopause. Prevalence and quality of life in Spanish postmenopausal women. The GENISSE study. Climacteric. 2018;21(2):167–73.
Portman DJ, Gass ML. Vulvovaginal atrophy terminology consensus conference P. genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's sexual health and the North American Menopause Society. Maturitas. 2014;79(3):349–54.
Gandhi J, Chen A, Dagur G, Suh Y, Smith N, Cali B, et al. Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management. Am J Obstet Gynecol. 2016;215(6):704–11.
DiBonaventura M, Luo X, Moffatt M, Bushmakin AG, Kumar M, Bobula J. The association between vulvovaginal atrophy symptoms and quality of life among postmenopausal women in the United States and Western Europe. J Women's Health (Larchmt). 2015;24(9):713–22.
Indhavivadhana S, Leerasiri P, Rattanachaiyanont M, Laiwejpithaya S, Tanmahasamut P, Techatraisak K, et al. Vaginal atrophy and sexual dysfunction in current users of systemic postmenopausal hormone therapy. J Med Assoc Thail. 2010;93(6):667–75.
Pinkerton JV, Bushmakin AG, Komm BS, Abraham L. Relationship between changes in vulvar-vaginal atrophy and changes in sexual functioning. Maturitas. 2017;100:57–63.
Nappi RE, Kokot-Kierepa M. Vaginal health: insights, views & attitudes (VIVA)—results from an international survey. Climacteric. 2012;15(1):36–44.
Nappi RE, Kokot-Kierepa M. Women's voices in the menopause: results from an international survey on vaginal atrophy. Maturitas. 2010;67(3):233–8.
Mac Bride MB, Rhodes DJ, Shuster LT. Vulvovaginal atrophy. Mayo Clin Proc. 2010;85(1):87–94.
Kowalcek I, Rotte D, Banz C, Diedrich K. Women's attitude and perceptions towards menopause in different cultures. Cross-cultural and intra-cultural comparison of pre-menopausal and post-menopausal women in Germany and in Papua New Guinea. Maturitas. 2005;51(3):227–35.
Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the international continence society. Am J Obstet Gynecol. 2002;187(1):116–26.
Palacios S, Castelo-Branco C, Currie H, Mijatovic V, Nappi RE, Simon J, et al. Update on management of genitourinary syndrome of menopause: a practical guide. Maturitas. 2015;82(3):308–13.
Blakeman PJ, Hilton P, Bulmer JN. Oestrogen and progesterone receptor expression in the female lower urinary tract, with reference to oestrogen status. BJU Int. 2000;86(1):32–8.
Robinson D, Cardozo L. Estrogens and the lower urinary tract. Neurourol Urodyn. 2011;30(5):754–7.
Banakhar MA, Al-Shaiji TF, Hassouna MM. Pathophysiology of overactive bladder. Int Urogynecol J. 2012;23(8):975–82.
Cervigni M, Gambacciani M. Female urinary stress incontinence. Climacteric. 2015;18(Suppl 1):30–6.
Erekson EA, Li FY, Martin DK, Fried TR. Vulvovaginal symptoms prevalence in postmenopausal women and relationship to other menopausal symptoms and pelvic floor disorders. Menopause. 2016;23(4):368–75.
Santoro N, Komi J. Prevalence and impact of vaginal symptoms among postmenopausal women. J Sex Med. 2009;6(8):2133–42.
Huang KE, Xu L, I NN, Jaisamrarn U. The Asian menopause survey: knowledge, perceptions, hormone treatment and sexual function. Maturitas. 2010;65(3):276–83.
Nappi RE, Lachowsky M. Menopause and sexuality: prevalence of symptoms and impact on quality of life. Maturitas. 2009;63(2):138–41.
Dennerstein L, Lehert P. Women's sexual functioning, lifestyle, mid-age, and menopause in 12 European countries. Menopause. 2004;11(6 Pt 2):778–85.
Chedraui P, Perez-Lopez FR, San Miguel G, Avila C. Assessment of sexuality among middle-aged women using the female sexual function index. Climacteric. 2009;12(3):213–21.
Peeyananjarassri K, Liabsuetrakul T, Soonthornpun K, Choobun T, Manopsilp P. Sexual functioning in postmenopausal women not taking hormone therapy in the gynecological and menopause clinic, Songklanagarind Hospital measured by female sexual function index questionnaire. J Med Assoc Thail. 2008;91(5):625–32.
Sturdee DW, Panay N. International menopause society writing G. recommendations for the management of postmenopausal vaginal atrophy. Climacteric. 2010;13(6):509–22.
Cody JD, Jacobs ML, Richardson K, Moehrer B, Hextall A. Oestrogen therapy for urinary incontinence in post-menopausal women. Cochrane Database Syst Rev. 2012;10:CD001405.
Hendrix SL, Cochrane BB, Nygaard IE, Handa VL, Barnabei VM, Iglesia C, et al. Effects of estrogen with and without progestin on urinary incontinence. JAMA. 2005;293(8):935–48.
Long CY, Liu CM, Hsu SC, Chen YH, Wu CH, Tsai EM. A randomized comparative study of the effects of oral and topical estrogen therapy on the lower urinary tract of hysterectomized postmenopausal women. Fertil Steril. 2006;85(1):155–60.
Perrotta C, Aznar M, Mejia R, Albert X, Ng CW. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women. Cochrane Database Syst Rev. 2008;2:CD005131.
Iglesia CB. What's new in the world of postmenopausal sex? Curr Opin Obstet Gynecol. 2016;28(5):449–54.
Acknowledgements
The authors thank the staff, nurses and resident trainees of the Menopausal Clinic and the participating patients.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors report no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Srisukho, S., Pantasri, T., Piyamongkol, W. et al. The experience of genitourinary syndrome of menopause (GSM) among Thai postmenopausal women: the non-reporting issue. Int Urogynecol J 30, 1843–1847 (2019). https://doi.org/10.1007/s00192-019-03991-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00192-019-03991-0